These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3514103)

  • 21. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
    Le Faou A; Rio A
    Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Branhamella infection].
    Nagatake T
    Rinsho Byori; 1985 Aug; 33(8):884-91. PubMed ID: 3908748
    [No Abstract]   [Full Text] [Related]  

  • 24. The occurrence of Branhamella catarrhalis and other commensal Neisseriaceae in clinical sputum specimens in Lagos, Nigeria.
    Obi MC; Animashaun T; Odugbemi T
    Eur J Epidemiol; 1990 Sep; 6(3):323-5. PubMed ID: 2123801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance of microorganisms involved in ear, nose and throat infections.
    Baquero F; Loza E
    Pediatr Infect Dis J; 1994 Jan; 13(1 Suppl 1):S9-14; discussion S20-2. PubMed ID: 8159522
    [No Abstract]   [Full Text] [Related]  

  • 26. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. a. Branhamella catarrhalis infection].
    Nagatake T; Rikitomi N; Tao M; Watanabe K; Mbaki N; Matsumoto K
    Nihon Rinsho; 1987 Mar; 45(3):604-10. PubMed ID: 3599486
    [No Abstract]   [Full Text] [Related]  

  • 28. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
    Nicotra B; Rivera M; Luman JI; Wallace RJ
    Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K; Chang BJ; Mee BJ; Riley TV
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
    Stobberingh EE; van Eck HJ; Houben AW; van Boven CP
    Drugs; 1986; 31 Suppl 3():23-7. PubMed ID: 3488194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 34. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of Branhamella catarrhalis to oral antibiotics.
    Kallings I
    Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
    Felmingham D; Robbins MJ; Tesfaslasie Y; Harding I; Shrimpton S; Grüneberg RN
    J Antimicrob Chemother; 1998 Mar; 41(3):411-5. PubMed ID: 9578171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ampicillin resistance in Haemophilus influenzae--test methods for the activity of acylureidopenicillins, cephamycins and new cephalosporins.
    Newsom SW; Matthews J
    J Antimicrob Chemother; 1982 Dec; 10(6):527-32. PubMed ID: 6984444
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower respiratory tract infection due to Branhamella catarrhalis, two case reports.
    Kambal AM; Chowdhury MN; Tongia RK; Chagla AH
    Trop Geogr Med; 1986 Dec; 38(4):418-20. PubMed ID: 3810847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.
    Brorson JE; Martinell J; Wilske H
    J Antimicrob Chemother; 1981 Feb; 7(2):208-9. PubMed ID: 6971288
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.